Acute changes in circulating hormones in older patients with impaired ventricular function undergoing on-pump

M Maggio1, G P Ceda, G De Cicco

  • 1Longitudinal Studies Section, Clinical Research Branch, National Institute on Aging (NIA), National Institutes of Health (NIH), USA.

Insights

Coronary artery bypass grafting (CABG) with cardiopulmonary bypass (CPB) significantly alters hormone levels in elderly patients. These changes, including decreased testosterone and IGF-I, may explain longer recovery times after cardiac surgery.

Area of Science:

  • Endocrinology
  • Cardiovascular Surgery
  • Geriatrics

Background:

  • Coronary artery bypass grafting (CABG) using cardiopulmonary bypass (CPB) triggers an acute stress response.
  • Hormonal changes during CPB may contribute to complications in older adults undergoing CABG.
  • Investigating these hormonal shifts is crucial for understanding post-operative recovery in the elderly.

Purpose of the Study:

  • To examine alterations in circulating anabolic and catabolic hormones in elderly patients during and after CABG with CPB.
  • To identify specific hormonal changes associated with the acute stress response to cardiac surgery in older individuals.

Main Methods:

  • An intervention case study design was employed.
  • Hormone levels (Cortisol, DHEA, DHEAS, LH, estradiol, total testosterone, SHBG, IGF-I) were measured in 19 elderly patients (aged 62-80) before and at multiple time points after CABG.
  • Patients had coronary artery disease and reduced ejection fraction (<40%).

Main Results:

  • Post-CABG surgery, serum Insulin-like Growth Factor-I (IGF-I) levels significantly decreased (p<0.001) in both sexes.
  • Cortisol (Cort), Dehydroepiandrosterone sulfate (DHEAS), and estradiol (E2) levels significantly increased in both men and women.
  • Total testosterone (Te) levels showed sex-specific changes: a significant decline in men and a significant increase in women.

Conclusions:

  • CABG with CPB induces significant hormonal alterations in elderly patients, including a marked decrease in testosterone in older men and a decline in IGF-I in both sexes.
  • Elevated cortisol levels were observed in both sexes following the procedure.
  • These hormonal shifts may partially account for the extended rehabilitation period required by elderly patients after CABG.
Abstract

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...